Miraean Pharmaceutical made waves in the industry with the grand launch of its flagship product line, Eagle 25, at an exclusive event held at Shangri-La. The highly anticipated occasion brought together business executives, stakeholders, and industry professionals, generating excitement around the company’s newest innovations.

The event opened with a warm welcome, where guests were greeted with an interactive photo wall and an exclusive raffle to set the celebratory tone. A cocktail networking session allowed attendees to connect before the main program.

Miraean Pharmaceutical’s introduction was led by Ms. Ana Han, who highlighted the company’s mission, vision, and milestones through an engaging corporate presentation. Japeth Aguilar then took the stage for a keynote speech, offering insight into the inspiration behind Eagle 25. The highlight of the evening came with the unveiling of three new Eagle 25 products, which were met with enthusiasm and applause from the audience.

Chairman Mr. Harry Kim addressed the attendees, outlining his vision for Miraean Pharmaceutical’s future and reinforcing the company’s dedication to innovation and excellence. His speech resonated with the audience, solidifying the brand’s commitment to advancing the pharmaceutical industry.

The event’s energy remained high with special performances from SBTown artists YGIG, PLUUS, and Darlene, who captivated the audience with their dynamic acts. Guests enjoyed further networking opportunities, participated in an exciting raffle, and engaged in discussions about future collaborations and projects.

The evening closed with a heartfelt gratitude speech from Japeth Aguilar and Chairman Kim, recognizing the contributions of sponsors, partners, and attendees who made the event a success. The after-party provided a lively conclusion, allowing guests to unwind and celebrate the launch in a festive atmosphere.

With a strong industry perception and an impactful unveiling, Eagle 25 is posed to redefine standards in the pharmaceutical sector, marking another milestone for Miraean Pharmaceutical.